Clinical Trials

Overview

About this study

The purpose of this study is to examine the impact of the COVID-19 pandemic on the physical activity habits and well-being of the general public.

The Coronavirus (COVID-19) outbreak was officially declared a pandemic on March 11, 2020 by the World Health Organization (WHO). Since then, many countries have introduced 'Social Distancing' guidelines/rules as a means of helping to stop the spread of the virus. Due to the ‘Social Distancing’ guidelines, the general population may be experiencing more sedentary behaviors and physical inactivity. Sedentary behaviors and physical inactivity are both well-known modifiable risk factors for cardiovascular disease and all-cause mortality. Thus, although Social Distancing is a necessary measure to prevent community transmission of COVID-19, we believe that a prolonged period of sedentariness may have unintended, longer-term impacts on public health and well-being in the future; health issues such as increased risk of chronic diseases that may persist well-beyond the duration of this pandemic. Therefore, it is important to determine the impact of the COVID-19 pandemic on the sedentary behaviors, physical activity levels and well-being of the general public in the United States, and worldwide. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information